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Background: Funded health research is being published in journals 
that many regard as “predatory”, deceptive, and non-credible. We do 
not currently know whether funders provide guidance on how to 
select a journal in which to publish funded health research. 
Methods: We identified the largest 46 philanthropic, public, 
development assistance, public-private partnership, and multilateral 
funders of health research by expenditure, globally as well as four 
public funders from lower-middle income countries, from the list at 
https://healthresearchfunders.org. One of us identified guidance on 
disseminating funded research from each funders’ website 
(August/September 2017), then extracted information about selecting 
journals, which was verified by another assessor. Discrepancies were 
resolved by discussion. Results were summarized descriptively. This 
research used publicly available information; we did not seek 
verification with funding bodies. 
Results: The majority (44/50) of sampled funders indicated funding 
health research. 38 (of 44, 86%) had publicly available information 
about disseminating funded research, typically called “policies” (29, 
76%). Of these 38, 36 (95%) mentioned journal publication for 
dissemination of which 13 (36.11%) offer variable guidance on 
selecting a journal, all of which relate to the funder’s open access 
mandate. Six funders (17%) outlined publisher requirements or 
features by which to select a journal. One funder linked to a document 
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providing features of journals to look for (e.g. listed in the Directory of 
Open Access Journals) and to be wary of (e.g., no journal scope 
statement, uses direct and unsolicited marketing). 
Conclusions: Few funders provided guidance on how to select a 
journal in which to publish funded research. Funders have a duty to 
ensure that the research they fund is discoverable by others. This 
research is a benchmark for funder guidance on journal selection 
prior to the January 2021 implementation of Plan S (a global, funder-
led initiative to ensure immediate, open access to funded, published 
research).
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Introduction
Biomedical research studies supported by well-known funding 
organizations such as the National Institutes of Health (NIH), 
are published in so-called “predatory” journals1. Predatory jour-
nals are regarded as non-credible and are criticized for failing 
to provide typical or expected publishing services and their lack 
of transparent operations2,3. Such services include peer review, 
long term preservation of content, and indexing in scientific, 
bibliographic databases. Among their many shortcomings, the 
potential failure of predatory journals to ensure permanent dis-
coverability of research threatens the integrity of the scientific 
record. Such research cannot contribute to science, thus wasting 
time, money, and resources1,4. Even if discovered, the potential 
impact and uptake of funded research in predatory journals may 
be limited due to being published in a perceived untrustworthy 
source. While benefits from investments in research are difficult to 
quantify5. One way funders measure returns on investments 
is by tracking research outputs, including scholarly journal 
publications6. Predatory journals may limit returns on funders’ 
investments by undermining the intended promise of schol-
arly publishing – to enable the results of research to be known 
for others to build upon7. 
Health research funders ought to be concerned that the funds 
they provide may be wasted or contribute to research waste as 
a result of funded research being published in predatory jour-
nals. They may be supporting research that is not identifiable 
or able to be found if published in predatory journals, poten-
tially wasting millions of dollars of research funding. When 
research is easily identifiable it can reduce unintentional redun-
dancies in research efforts and investments. Additional wast-
age occurs when funder investments are used to pay for article 
processing charges (APCs). In biomedicine, research grants 
and national funding agencies are the largest source of funds 
supporting publication of at least 50% of open access articles8.
Funders & open access
Most major health research funders mandate that funded 
research outputs be open access9. Open access mandates typi-
cally require researchers to ensure that research (and sometimes 
data) is published in an open access journal or is deposited in 
a publicly accessible digital repository (regardless of whether the 
publication was published in an open access journal), or both. 
Some journals may impose an embargo period only after which 
an article is made publicly available or can be archived in a 
repository (i.e., delayed-access journals). Many funders’ poli-
cies allow for such delays in open access to accommodate 
publishers’ preferences.
Open access policies are one way for funders to direct 
funded researchers towards publishing in credible journals 
abiding by established open access tenets10:
     1.      Research is/should be freely available and accessible to 
anyone.
     2.      The copyright accompanying published work should 
be open, allowing for free use and re-use (i.e., allowing 
research to be freely built on/adapted with attribution).
To facilitate researcher adherence with funder open access 
policies, many biomedical journals offering open access have 
agreements with the PubMed Central (PMC) repository to auto-
matically deposit their published content on authors’ behalf11. 
Additionally, researchers funded by the NIH and 13 partner 
funding organizations in the USA can upload funder-supported 
publications to PMC from journals without PMC agreements12. 
Likewise, 29 funders from across Europe can submit funder- 
supported research to Europe PMC (which is mirrored in 
PMC)13. For some of these organizations, such as the NIH and 
Wellcome Trust, archiving in PMC or Europe PMC, respectively, 
is mandatory.
In a possible attempt to attract submissions, predatory jour-
nals appear to market themselves as ‘open access’14,15. While 
research in them may indeed be free to access, discovery of 
their content in scientifically-curated databases is sparse and 
inconsistent16–18. Predatory journal articles may haphazardly 
appear in search engines such as Google Scholar (which indexes 
anything that appears formatted as a scholarly article) or in 
PubMed (since it includes author-uploaded articles from PMC)19. 
Additionally, we do not know whether the contents of unin-
dexed/unarchived journals will be perpetually available if a jour-
nal ceases to operate. Such preservation is typically achieved 
through journal/publisher agreements with digital preserva-
tion providers (e.g. Lots of Copies Keep Stuff Safe, LOCKSS). 
For journals indexed in Medline, for example, this is a prereq-
uisite of indexing20; PMC functions as a preservation service 
(i.e., has a remit to preserve content funded by public money)21. 
It is unknown whether predatory journals, not formally indexed 
in Medline, PMC, or other databases with similar requirements, 
have digital preservation arrangements.
Most researchers have a limited understanding of what open 
access means beyond making research free to read22–25. Free use 
and unrestricted re-use of research is a fundamental compo-
nent of open access, and licensing that permits this is a regular 
component of open access journals26. Journals running nefari-
ous and deceptive publishing operations have likely benefited 
from or exploited authors’ lack of awareness27. Indeed, few 
           Amendments from Version 1
We have addressed/responded to the suggestions from 
reviewers with the following changes:
- simplified the wording/sentence structure in the introduction 
and discussion sections.
- clarified the relevance of this research to health research 
funders in the introduction (i.e., discoverability, uptake).
- added more detail on how extraction items were devised.
- indicated the name of an excluded funder in Figure 1.
- acknowledged, in the limitations section, the potential benefit of 




Page 3 of 31
F1000Research 2021, 10:100 Last updated: 30 JUL 2021
predatory journals mention licensing for articles or provide 
information on the use and re-use of published research26. With-
out explicit licensing for published articles, the legalities around 
distributing or building on research in predatory journals, 
for example, is uncertain. Whether researchers are deceived by 
predatory journals or are knowingly seeking easy and rapid pub-
lications in them (these journals tend to deliver quicker turna-
round time than credible journals due to subpar or non-existent 
peer review28,29), they are likely breaching the open access 
policies set by their funders.
In January 2017, the Bill & Melinda Gates Foundation 
implemented a policy mandating open access to research pub-
lications and data, without delay for all funded research30. In 
February 2017, they initiated a one-year partnership pilot with 
the American Association for the Advancement of Science 
(AAAS) to enable Gates-funded research to be published as 
open access in five AAAS journals, including Science31. The 
Gates-AAAS partnership seemed to inspire several other 
influential journals (i.e., New England Journal of Medicine, 
Proceedings of the National Academy of Sciences) to intro-
duce policies ensuring permanent open access for Gates-funded 
research32.
In January 2021, a number of international funders (includ-
ing UK Research and Innovation, the Gates Foundation, Well-
come Trust, and the World Health Organization), led by Science 
Europe (a group representing funders across Europe), delivered 
a radical change to the way that funded research is published, 
via Plan S (coalition-s.org). Plan S, in part, requires research 
funders to mandate open access to funded research through 
publication in an open access journal or platform; requiring 
publications to be immediately available through an open access 
repository upon publication. To support this, agreed funders 
will pay the cost of article publishing charges (APCs) (up 
to a yet unannounced limit) to journals that are immediately 
and wholly open access (sometimes referred to as ‘gold’ open 
access).
Whether health research funding bodies, prior to Plan S, 
provide funded researchers with guidance or support towards 
selecting publishing journals in line with their policies and 
which facilitate proper (and permanent) access to research, and 
whether they monitor such policies, is unknown. Previous stud-
ies confirm that many non-commercial health research funders’ 
have policies requiring open access to completed research or 
results via publication or otherwise33,34. Yet none seem to 
have assessed whether funders provide any specific informa-
tion to researchers to facilitate their choice of publishing jour-
nal. For public or charitable funders, providing such guidance 
or support may be one way of ensuring responsible stewardship 
of public or donor funds. While research publication routes exist 
beyond scientific journals (e.g., preprint servers, repositories) 
the present project examines journals as the primary vehicles 
of research dissemination due to funders’ and academia’s reli-
ance on them as a gauge of research impact/productivity. The 
current work will establish a pre-Plan S baseline of health 
research funders’ guidance on selecting journals in which to 
publish funded research.
The aim of this research is to describe the policies and recom-
mendations of major health research funding bodies regarding 
suitable journals for funded research.
Methods
We considered the public websites of 50 health funding bodies 
for statements, guidance, or policies specifically mentioning the 
publication of funded research. Detailed methods and rationale 
for this study are elaborated in an a priori study protocol 
(https://doi.org/10.17605/OSF.IO/J6CSK) and summarized below.
Data source
Global funding bodies with the largest documented health 
research expenditures were sampled from the curated Health 
Research Funder’s list found at: www.healthresearchfunders.org35. 
The list was developed as part of an unfunded post-doctoral 
project by researchers in the Netherlands35. It was last updated 
in 2016; expenditure data are reported in 2013 US dollars 
(USD, accounting for inflation/deflation rates by country). 
A detailed account of the systematic process used to iden-
tify funders and obtain expenditure data is found here: 
http://www.healthresearchfunders.org/faq/. At the time of retrieval 
for this study (August 2017), 287 health research funding 
bodies from 30 countries were included on the list. The list 
distinguishes five categories of funders: [1] philanthropic funders 
(n=194), [2] public funders (n=77), [3] public funders who 
fund health research through Official Development Assistance 
(public ODA)1 (n=8), [4] multilateral funders (funding across 
countries) (n=7), and [5] public-private partnerships (PPP) (n=1) 
(Table 1). While there are some inequities in its coverage 
(e.g. public funders were selected from only G20 countries; pau-
city of funders from low income countries), the list is likely the 
most comprehensive source of global health research funder 
expenditure information in existence (personal communication, 
Dr. Beverley Holmes, CEO, Michael Smith Foundation for 
Health Research) and has been used to construct samples in 
at least two other studies34,36. This study excludes commercial 
funders since their expenditure data are not publicly or readily 
available.
Sampling
To construct our sample, we sought up to 15 funders with 
the largest expenditures from each of the five funder categories 
from the list at www.healthresearchfunders.org, and aimed to 
include all listed lower income countries (n=4) if they were not 
otherwise represented in the sample. We included the latter group 
of funders in order to ensure representation from lower income 
countries, since researchers and journals from these countries have 
been disproportionately implicated in predatory publishing26,37. 
Working with the available number of funders in each category 
(Table 1), we ended up with 50 funders: 15 philanthropic, 15 
public, eight public ODA, seven multilateral, one PPP, and four 
lower-middle income country funders.
1ODA is a term coined by the Development Assistance Committee of the 
Organisation for Economic Co-operation and Development (https://data.
oecd.org/oda/net-oda.htm)
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Philanthropic Public Public-ODA Multilateral PPP
high income: non-OECD† None listed 274.31(5)‡ None listed None listed None listed
high income: OECD 4995.25 (194)§ 39847.47 (50)** 344.40 (8) None listed None listed
upper middle income No data (1) 1540.87 (13)†† None listed None listed None listed
lower middle income None listed 140.26 (4) ‡ None listed None listed None listed
low income None listed None listed None listed None listed None listed
Income level not stated None listed 6111.78 (5) None listed 137.09 (7) ** 455.36 (1)
*Created from data at healthresearchfunders.org.
† OECD: Organisation for Economic Co-operation and Development.
‡ Includes 3 funders with no expenditure data available.
§ Includes 11 funders with no expenditure data available.
** Includes 1 funder with no expenditure data available.
†† Includes 5 funders with no expenditure data available.
In line with previous investigations into health research funder 
policies34,38, we expected that guidance for funded researchers 
would be publicly available and easily obtained. For each included 
funder, one of us (LS) visited the website using the URL pro-
vided by www.healthresearchfunders.org, or if the URL was not 
working, found it through a Google search using the funder 
name. When a funder’s website could not be located/did not work 
or when the funder was a duplicate, the next largest funder 
on the list was used. For each funder, we sought and down-
loaded the website section on policies for funded research in 
August-September 2017. If no specific policies were found, 
we searched the SHERPA (Securing a Hybrid Environ-
ment for Research Preservation and Access)/Juliet database 
(www.sherpa.ac.uk/juliet/index.php), which lists and links con-
ditions for open access publication for some funders (though 
this is incomplete as it is reliant on voluntary contributions from 
funders and other organizations [e.g., libraries] tracking funder 
policies). If a funder’s website did not mention funding health 
research (i.e., funded other scientific research) or if the funder 
did not specifically award grants for research, the funding 
body was excluded from the sample and replaced with the next 
largest funder (by expenditure), where possible. Reasons for 
exclusion are documented in Figure 1.
Data extraction
One assessor (LS) extracted information from the downloaded 
policy documents into an online form in Distiller SR, and a 
second assessor (KDC or MJP) verified the extracted data. 
Discrepancies were resolved by discussion. If additional docu-
ments were identified during extraction, we saved them and 
searched them for the desired data. The verification process led to 
clarifications in collected data or provided additional information. 
Since no reference standard for funder policies on publishing 
exists, the extracted items were derived de novo by the study 
team; no formal consensus process was used. The following 
information was assessed or extracted, as available:
     •      Any statement(s) about the dissemination of outputs from 
funded research
     •      Policy or recommendations about publication of funded 
research
     •      Policies or recommendations on research/data accessibility
     •      Policies or recommendations on journal quality, impact 
factor or other metric, ethical standards, and indexing of 
funded research;
     •      Whether/what information is provided to researchers 
about predatory or substandard journals, or about journal 
credibility
     •      Strength of any aforementioned policies/recommendations 
(‘must’, ‘should’, or ‘suggested’)
     •      For publication policies, whether adherence will be 
monitored
     •      For publication policies, whether consequences of 
non-adherence are listed
If non-English websites or documents were encountered 
and an English-language version was not available on the 
website, Google Translate was used to automatically trans-
late the websites and documents. Google Translate has recently 
shown 85%–97% accuracy across nine languages for translating 
health research studies39, including the languages encountered 
in this study (French and German).
Data analysis
We summarized data descriptively by calculating proportions for 
dichotomous data; the date of funder policies/recommendations 
were summarized as medians and interquartile range.
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2Any European Commission funding program that explicitly stated 
using the European Horizon 2020 guidelines for grantees were jointly 
represented as “European Commission”. (Figure 1)
Figure 1. Flow diagram for selection of included funders.
Protocol deviations
In the protocol for this study, we stated that we wanted to 
determine whether there were differences in the number of funders 
with policies/statements about journal quality and predatory 
publishing based on the income-level of the funder country or 
country being funded. However, as only four funders from 
lower-middle income countries and none from low income 
countries were on the list we sampled from, there were not 
enough funders to enable meaningful comparisons between 
higher income and lower income countries.
Results
For the 50 funding bodies originally identified using the described 
sampling technique, three allocated money from a funder 
(European Commission2) already in the sample and were replaced 
with the next organizations on the list. One of the replacement 
funders also allocated money from an included funder and was 
also replaced. Two funders funded non-health research and four 
funders did not list any research grants (and appeared to fund 
health development initiatives) and could not be evaluated for 
our purposes. Overall, six funders were excluded and lacked 
replacements in the categories they belonged to. 44 funders 
remained in the sample for which grant policies and guide-
lines were sought (Figure 1). 35 funders are from high income 
countries, one from upper-middle income (China), three are 
from a lower-middle income country (India), and five are not 
classified by income level because they are multilateral (n=3) or 
fund across the European Union (EU) (n=2, Table 2).
38 of 44 funders (86%) had publicly available information for 
grantees about disseminating funded research outputs (Table 3). 
Of the six funders that did not have publicly available infor-
mation, five are from high-income countries (US, Germany, 
France, UK) and one funds research in the EU through public-
private partnership. Three are philanthropic organizations and 
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two are public-ODA funders. Information about disseminating 
research was contained within “policies” for 29/38 (76%) funders, 
“recommendations” (suggestions and guidance) for 8/38 (21%) 
of funders, and as a “code of conduct” for one funder (Table 3). 
All but one policy/recommendation referred to funded research 
(including results) as the unit of dissemination (37/38, 97%). 
Over a third of policies/recommendations also specifically 
mentioned the dissemination of “data” (25/38, 66%). The median 
implementation date or date listed on collected documents was 
September 2014 (IQR: Apr 2012 to Apr 2016, n=35).
Open access and journal selection
36 of 38 policies/recommendations (95%) specifically referred 
to publication in a journal as one form of dissemination for 
completed research (Table 4). 31 of these (86%) mentioned that 
research should be open access, either through journal publica-
tion (n=24, 77%) or through self-archiving the final report or 
accepted manuscript in a freely accessible repository (such as 
PMC) (n=30, 97%). One funder from India (Indian Council of 
Medical Research), one from France (Institut National de la Santé 
Et de la Recherche Médicale, INSERM), and three from the USA 
(US Department of Defense, Congressionally Directed Medical 
Research Program, and the American Cancer Society) did not 
mention open access in their policies about research 
dissemination.
13 of 36 (36%) policies recommending publication contained 
some guidance on how to select a journal and six (17%) listed 
features or requirements of publishers or journals for research-
ers to look for (Table 5). These six are described here. Only 
one funder policy (NIH) included a definition of a journal (i.e., 
either a publication listed in the journal section of the National 
Library of Medicine or one meeting stated criteria). And 
only one funder policy (Canadian International Development 
Research Council, IDRC) appeared to provide any informa-
tion about ‘questionable’ journals in a guidance document enti-
tled “Publishing in Open Access Journals”. The document 
lists journal features to “look for” and to “be wary of” and 
mentions Beall’s List3 as a resource (Table 5). One policy (Deut-
sche Forschungsgemeinschaft/German Research Foundation, 
DFG) linked to Think, Check, Submit (www.thinkchecksub-
mit.org) – an initiative to facilitate researchers’ assessment of 
the credentials of a journal – on a page supplementing their 
open access policy listing open access resources. Two funders 
distributing APC fees through the Charitable Open Access 
Fund (Cancer Research UK and Wellcome Trust) list the 
Table 2. Description of funders (n=44).
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ii All funders from India.
iii Income-level not available since funders distributing funds across 
multiple countries (3 multilateral funders and 2 European Union funders).
iv No funders from “Low income” countries in sample.
Table 3. Funder Policies on publishing.
n(%)
Publicly available webpage or document(s) on 
funder website discussing dissemination of 
research outputsa
38 (86%)


















Date of effectf [median (IQR)] Sept 2014 
(Apr 2012–
Apr 2016)
a Denominator = 44 funders with grant guidelines.
b Denominator = 38 funders with statements about research outputs.
c Policy: uses the words “policy”, “must”, “require”; Recommendation/
Guideline: uses the words “recommendation” “recommend”, “suggest”, 
“should”, “guideline”.
d Other - described as “Code of Conduct”.
e Verbatim: activities of funded organizations; all research outputs, news 
releases; photos; any and all other published material referencing the 
research project or grant; code; research materials; protocols; research 
resources including, but are not limited to, the full range of tools that 
scientists and technicians use in the laboratory, such as cell lines, 
antibodies, reagents, animal models, growth factors, combinatorial 
chemistry, DNA libraries, clones and cloning tools (such as PCR), methods, 
laboratory equipment and machines; presentations; media interviews; 
and other professional activities; ‘research tools’; metadata; bibliographic 
metadata; supplementary materials; other supporting artefacts, research 
resources/tools.
f Out of 35 funders listing this information. Date of implementation was 
used if available, otherwise, date of document or last update was used. 
When only year was given, January was used as default month; when a date 
range was given the most recent date was used.
3Beall’s List is an archived listing of potential predatory journals and 
publishers, as determined by librarian Jeffrey Beall between 2011 and 2017, 
https://web.archive.org/web/20170103170903/https://scholarlyoa.com/
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Journal Impact Factor ( JIF) 
Any measure/description 
of journal quality4 
Peer review 















1 Denominator: 36 funders mentioning journal publication.
2 See Table 5 for verbatim text of statements about journal selection.
3 See Table 5 for verbatim text of statements about journal credibility.
4 excluding JIF.
5 2 funders indicate journal should be “high quality, peer reviewed journal”; 
1 funder indicates journal should be “quality peer-reviewed journal”; 1 
funder indicates what a good journal is: “Good journals have guidelines 
for reviewers of manuscripts committing them to strict confidentiality/
to disclose conflicts of interest and promise to respond to submitted 
manuscripts within a specified, short time limit, and correspondingly set 
their reviewers short time limits for their comments.”
6 See Table 6 for transparency or ethics standards for publications.
7 Other: 1 funder encourages publication in “primary scientific journals”; 
1 funder states “models and mechanisms for publication and access to 
research must be both efficient and cost effective”;.
Other journal characteristics mentioned by funders
Most funders mentioned that funded research should be peer 
reviewed or published in a peer reviewed journal (Table 4). 
Four funders made non-specific reference to selecting a “good” 
or “quality” journal in relation to publication of funded research; 
none mentioned the journal impact factor. Eight funders made 
statements about publication transparency or ethics. For instance, 
one funder discussed reproducibility in published research, three 
mentioned adherence to reporting guidelines, and at least six 
asked that metadata accompany published articles (Table 6).
Adherence to policies/recommendations
Of 38 policies/recommendations providing information about 
disseminating research outputs, only nine (24%) stated that 
they monitor adherence to either a policy (n=7) or recommen-
dation (n=2); two philanthropic funders (Wellcome Trust and 
Bill & Melinda Gates Foundation) specified that they would 
evaluate publications of funded research reported to them to 
ensure they are published in journals meeting the funder’s outlined 
publishing requirements (Table 7). No monitoring or adherence 
data appears to be publicly available. Only five (13%) funders 
with policies or recommendations about journal publication 
indicated that there would be consequences for non-adherence. 
And only two of those (Wellcome Trust and NIH) stated that 
they would withhold or suspend payments if articles are not 
made open access.
Discussion
Most health research funders appear to have active policies 
about the dissemination of funded research, typically about open 
access which often include statements about journal publication. 
Few policies contain guidance on how to select journals, list 
features of journals meeting funder requirements, or about the 
credibility of publishing outlets. Only one health research fund-
ing organization (IDRC) made specific reference to the “question-
able journals” at the time of data collection (August-September 
2017). Additionally, few policies describe whether funded out-
puts are monitored for compliance with funders’ dissemination 
policies, and few describe any consequences for researchers’ 
non-adherence to their policies. Information is not available 
on whether the NIH or Wellcome Trust, both of whom prom-
ise to withhold or suspend grant funds for breaching their 
open access policies, have actually ever done so9.
For many of the funders in our sample, information to guide 
research publication was found across multiple documents and 
not always within open access policy statements/documents 
where publication is mentioned. For example, the only guidance 
we identified that referred to predatory journals (IDRC) was con-
tained in a PDF (entitled “Publishing in Open Access Journals”) 
separate from the funders’ main open access policy. The 
policy did not flag that the document contained information 
about predatory/questionable/non-credible journals. This unob-
vious placement of guidance or expectations around journal selec-
tion relies on researchers’ curiosity or knowledge that important 
requirements of journals whose APCs are eligible for pay-
ment through the fund. The Bill and Melinda Gates Foundation 
provide researchers with a portal (called Chronos) through which 
to submit manuscripts directly to pre-selected journals whose 
standards are in line with their requirements.
The policies of at least three funders (German Federal 
Ministry of Education and Research Indian [BMBF], Indian 
Department of Biotechnology [DBT], Indian Department of 
Science & Technology [DST]) include a statement that further 
to making research freely accessible, researchers’ choice of 
journal was unrestricted.
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Table 5. Funder statements on journal selection, requirements & credibility.
Funder Journal Selection Specific publisher/journal requirements or acceptability/credibility features Name of webpage/source 
document
Bill & Melinda Gates Foundation “Open access publishing is a non-negotiable term included 
in all grant agreements as of January 1, 2015. Please log 
into Chronos to search and find journals that offer open 
access options as required by the foundation’s policy.” 
“Our Open Access policy contains the following elements: 
1. Publications Are Discoverable and Accessible Online. 
Publications will be deposited in a specified repository(s) 
with proper tagging of metadata. 
2. Publication Will Be On “Open Access” Terms. All 
publications shall be published under the Creative 
Commons Attribution 4.0 Generic License (CC BY 4.0) 
or an equivalent license. This will permit all users of the 
publication to copy and redistribute the material in any 
medium or format and transform and build upon the 
material, including for any purpose (including commercial) 
without further permission or fees being required. 
3. Foundation Will Pay Necessary Fees. The foundation 
would pay reasonable fees required by a publisher to effect 
publication on these terms. 
4. Publications Will Be Accessible and Open Immediately. 
All publications shall be available immediately upon their 
publication, without any embargo period. An embargo 
period is the period during which the publisher will require 
a subscription or the payment of a fee to gain access to the 
publication. We are, however, providing a transition period 
of up to two years from the effective date of the policy (or 
until January 1, 2017). During the transition period, the 
foundation will allow publications in journals that provide 
up to a 12-month embargo period...”
“Chronos will list the most current information about which journals offer these [open access] 
options, i.e., the listing for Science will reflect the current agreement between the Gates Foundation 
and the American Association for the Advancement of Science (AAAS).”
Open Access Policy - Frequently 
Asked Questions
Bloodwise “If the journal is not compliant with our open access policy, 
grant holders can request from Bloodwise that grant 
underspend is used to cover the cost with a justification for 
publishing in a non-compliant journal”/”Researchers can 
determine which publishers are compliant with this policy 
by referring to the SHERPA/FACT database and checking 
against the Wellcome Trust’s policy, which has the same 
stipulations.”
None stated Project grants – guidance for 
applicants
British Heart Foundation All of our Grantholders submitting manuscripts to journals 
should find out in advance whether the publisher supports 
open access and how they can comply with paragraph 2 
above.
None stated Open Access Policies
Cancer Research UK “The journal you publish in must be published by a 
publisher who has agreed to the COAF/Wellcome Trust 
publisher requirements. Cancer Research UK and the 
Charity Open Access Fund (COAF) will only fund APCs where 
the publisher has agreed to the COAF/Wellcome Trust 
publisher requirements. These publisher requirements 
set out the open access services that publishers must 
agree to provide when they charge APCs for COAF-funded 
researchers. Most major publishers and many smaller 
publishers have signed up to these requirements. If you 
would like to check that the publisher of your chosen 
journal is compliant, search the SHERPA/FACT database 
here. Select the name of the relevant journal and Cancer 
Research UK as your funder – as long as the results show at 
least one ‘tick’ (✓), the journal is compliant by that route.”
“Publishers who want to provide open access publishing services for Wellcome and Charity Open 
Access Fund (COAF) grantholders through peer-reviewed journals based on article processing 
charges (APCs) must commit to providing a service that meets our requirements. 
Our open access policy (/funding/managing-grant/open-access-policy) states that when Wellcome 
funds are used to pay an APC, the article must be deposited, at the time of publication in PubMed 
Central (PMC). It will then be mirrored to Europe PMC. 
All deposited articles must be made available under the Creative Commons Attribution (CC-BY) 
Licence. COAF follows the same policy. 
Wellcome and COAF’s open access policies and requirements are designed to maximise the 
availability and reuse of publications. 
We hope that publishers will continue to support us and our grantholders in this endeavour. We 
recognise that relationships in the publication process are not straightforward – we have grant-
funding relationships with researchers, who then establish relationships with publishers. This can 
lead to confusion about what Wellcome and COAF expect from publishers. 
Our requirements clarify the service that publishers who receive Wellcome or COAF funds need to 
provide.”
Open Access Policy/Publisher 
Requirements
✓✓
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“The approved funds are only for the publication of essays in 
original Open Access journals. The funds may only be spent 
provided that the following conditions are met:…The articles 
to be published appear in journals whose contributions are 
all accessible to users free of charge (“genuine open access 
journals”) immediately after their publication on the Internet, 
and which apply the strict quality assurance procedures 
recognized in the relevant subject… The funds provided by 
the DFG may not be used to publish open essays in journals 
subject to subscription (according to the “Open Choice” 
model etc.) for Open Access.”* 
“Guiding ideas for choosing appropriate means of 
publication: http://thinkchecksubmit.org”
“Recommendation 12: Scientific journals shall make it clear in their guidelines for authors that they 
are committed to best international practice with regard to the originality of submitted papers 
and the criteria for authorship.”/ “all good scientific journals report when a manuscript has been 
received and when – usually following peer review – it has been accepted”




“Scientific articles from projects funded by the BMBF should 
either be published directly under an open access model 
or be put into a suitable document server after expiry of 
an embargo deadline. The researchers remain free in their 
choice, whether and in which journal they want to publish”
None stated Press Release announcing 
Open Access Strategy
Howard Hughes Medical Institute “HHMI strongly encourages all HHMI laboratory heads to 
publish their original, peer-reviewed research in journals that 
make publications freely available and downloadable on-line 
immediately after publication (i.e. open access journals). 
If a laboratory head chooses to publish an original, peer-
reviewed research publication on which he or she is a major 
author in a journal that is not open access, the laboratory 
head is responsible for ensuring that the publication 
is freely available and downloadable on-line as soon as 
reasonably possible after publication, and in any event 
within twelve months of publication.”
None stated Public Access to Publications
Indian Department of 
Biotechnology (DBT)
“The DBT and DST recognize the right of researchers to 
publish their work in journals of their choice, because 
researchers are the best judges of where to publish their 
work. The DBT and DST expect that the recipients of 
funding will publish their research in high quality, peer-
reviewed journals.” AND “Results should be published in an 
appropriate form, usually as papers in refereed journals, 
with copies being made available through PubMed Central 
(PMC) and UK PubMed Central (UKPMC) as soon as 
possible and in any event within six months of the journal 
publisher’s official date of final publication.”




same as Indian Department of Biotechnology (DBT) None stated DBT and DST Open Access 
Policy
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Funder Journal Selection Specific publisher/journal requirements or acceptability/credibility features Name of webpage/source 
document
IDRC/Global Affairs Canada “Authors should carefully consider the quality standards 
of publications and ensure that appropriate peer review 
mechanisms are followed. The Directory of Open Access 
Journals, maintained by Infrastructure Services for Open 
Access (IS4OA), lists open access journals that have 
been reviewed for quality. Authors can also refer to the 
information guide Publishing in Open Access Journals, 
which lists journal quality indicators to evaluate potential 
publication outlets.”
While most open access journals are peer‐reviewed and high quality, there are a number of 
questionable journals, i.e. journals that do not subscribe to most or any of the practices of 
legitimate, academic journals. There is no single rule or test to indicate whether an open access 
journal is reputable. But here is what you should look for and what you should be wary of to avoid 
publishing in a questionable journal: 
Look for ... 
• Journal scope is well‐defined and clearly stated 
• Journal is affiliated with or sponsored by an established scholarly society or academic institution 
• Editor, editorial board are recognized experts in the field 
• Articles are within the scope of the journal and meet the standards of the discipline 
• Any publishing fees or charges are easily found on the journal website and clearly explained 
• Rights for use and re‐use of content at article level (e.g., Creative Commons CCBY licence) are    
clearly indicated 
• Articles have DOIs (Digital Object Identifier, e.g., doi:10.1111/j.1742‐9544.2011.00054.x) 
• An ISSN (International Standard Serial Number e.g. 1234‐5678) has been assigned 
• Publisher is a member of Open Access Scholarly Publishers Association (OASPA) 
• Journal is listed in the Directory of Open Access Journals (DOAJ) 
• Journal is included in established subject databases and/or indexes (e.g., Academic Search 
Complete, Medline, etc.) 
Be wary of ... 
• No journal scope statement or one that is vague 
• Website mimics other well‐known publishers’ site, or links or uses logos of recognisable entities 
although there is no actual connection 
• Journal title is very similar to title of a more established journal 
• Poorly maintained Web presence, including dead links, multiple spelling and grammatical 
mis‐ takes (on website and in articles) 
• No editor, editorial board, or editorial staff is listed, or they lack affiliation 
• Publisher is also the editor of the journal and/or editorial boards members serve on the board of 
multiple titles from the same publisher 
• Authors have several articles in the same issue 
• Publisher uses direct and unsolicited marketing (i.e., spamming) or advertising is obtrusive (to 
publish articles or serve on editorial board) 
• No information is provided about the publisher or location; either information is missing or does 
not match geographical area covered by the journal (e.g., “American Journal of ….” but published in 
Croatia) 
• Instructions to authors regarding peer review, copyright and/or fees (APCs), are not listed on 
web‐ site or are unclear 
• Publisher promises unusually rapid peer review and publication schedule Open Access 
• New (but self‐proclaimed “leading”) publisher with a large number of journals 
• Journal not listed in the Directory of Open Access Journals (DOAJ) 
• Claims to be indexed by Google and Google Scholar (or other search engines that crawl the Web) 
• Refers to bogus metrics meant to mimic Impact Factor (e.g., Journal Influence Factor, Global 
Impact Factor, etc.) 
• Publisher has a negative reputation (e.g., documented examples in Chronicle of Higher Education, 
list‐servs, etc.) 
• Journal or publisher appears on Beall’s List of Predatory Journals and Publishers 
Tools to find and evaluate open access journals: 
• Directory of Open Access Journals: http://doaj.org/ Online index of open access, peer‐reviewed 
journals 
• Beall’s List of Predatory Journals and Publishers: http://scholarlyoa.com/ List of potential, possible 
or probable questionable scholarly open access publishers and standalone journals 
• SHERPA/RoMEO: http://www.sherpa.ac.uk/romeo/ Online index of publisher copyright and 
self‐archiving policies
Open Access Policy for IDRC-
Funded Project Outputs/IDRC 
Publishing in Open Access 
Journals
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“NHMRC acknowledges that researchers take into 
account a wide range of factors in deciding on the best 
outlets for publications arising from their research. Such 
considerations include the status and reputation of a 
journal, book, publisher or conference, the peer review 
process of evaluating their research outputs, access by 
other stakeholders to their work, the likely impact of their 
work on users of research and the further dissemination 
and production of knowledge. Taking heed of these 
considerations, NHMRC wants to ensure the widest 
possible dissemination of the research supported by 
NHMRC funding, in the most effective manner and at the 
earliest opportunity.
None stated NHMRC OA policy
National Institutes of Health “Awardees must ensure that any publishing agreement 
allows the paper to be posted to PMC in accordance with 
the NIH Public Access Policy. NIH does not dictate the 
means by which awardees must do so, but does offer 
guidance in an FAQ on suggested wording for publishing 
agreements.”
“If a publication is in the journal section of the NLM catalog, NIH considers it to be a journal. 
Search the journal section of NLM Catalog (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals) for 
the journal by title, title abbreviation, or ISSN. Automatic suggestions will display as you type. If 
the publication is not on the list, NIH will consider it a journal for policy purposes if it meets all of 
the following criteria: Publication must meet the requirements for ISSN assignment; Publication 
content is issued over time under a common title; Publication is a collection of articles by different 
authors; Publication is intended to be published indefinitely; You may also submit the manuscript 
to NIHMS upon acceptance for publication for a determination.”
National Institutes of Health 
Plan for Increasing Access to 
Scientific Publications and 
Digital Scientific Data from NIH 
Funded Scientific Research/NIH 
FAQ on Public Access Policy
Wellcome Trust “We expect Wellcome-funded researchers to select 
publishing routes that ensure the work is available 
immediately on publication in its final published form, 
wherever such options exist for their publisher of choice 
and are compliant with our policy.” 
 
“The [Charitable Open Access Fund] fund can only be used 
for APCs where the publisher has agreed to our publishing 
requirements.” 
 
“Check that your journal of choice has a publishing policy 
compliant with our grant conditions. Wellcome-funded 
authors can use the SHERPA Funders’ and Authors’ 
Compliance Tool (http://www.sherpa.ac.uk/fact/) (SHERPA 
FACT) to check this.”
Same as Cancer Research UK Open Access Policy/Publisher 
Requirements
* “Open Choice” is a term used by the publisher Springer to refer to hybrid journals.
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Table 6. Transparency tools/activities mentioned by funders.
Funder Additional publication transparency actions/initiatives mentioned Source
Bill & Melinda Gates 
Foundation
“Publications Are Discoverable and Accessible Online: Publications will be deposited in a 





“Grant holders should make use of the ARRIVE guidelines when designing their experiments, 






Recommendation 7: Safeguarding and Storing of 
Primary Data. “Experiments and numerical calculations can only be repeated if all important 
steps are reproducible. For this purpose, they must be recorded. Every publication based 
on experiments or numerical simulations includes an obligatory chapter on “materials and 
methods” summing up these records in such a way that the work may be reproduced in another 
laboratory.”
Safeguarding Good Scientific Practice
European Commission “To be able to easily find the deposited publication, beneficiaries must also ensure open access 
– via the repository – to the bibliographic metadata that identify the deposited publication. This 
metadata must include a persistent identifier (such as the Digital Object Identifier, DOI) in order 
to allow easy and persistent referencing.”
European Research Council (ERC) Guidelines 
on Implementation of Open Access to Scientific 
Publications and Research Data
Indian Council of Medical 
Research
Researcher’s Relations with the Media and Publication Practices: “The term ‘misconduct in 
research’ means fabrication, falsification, plagiarism, selective omission of data and claiming 
that some data are missing, ignoring outliers without declaring it, not reporting data on side 
effects/ adverse reactions in a clinical trial, publication of post-hoc analysis without declaring it, 
gift authorship, not citing others’ work, not disclosing conflict of interest, redundant publication, 
and failure to adequately review existing research. The Commission on Research Integrity in 
US created by US Congress addresses the scientific, ethical, social and legal issues involving 
scientific misconduct in research. Consolidated standards of reporting trials (CONSORT) 
guidelines have been prescribed for publishing results of clinical research especially RCTs 
(Randomised Controlled Trials) and are available at http://www.consort-statement.org/.”
Ethical Guidelines for Biomedical Research on Human 
Participants
Institut Pasteur “To be able to easily find the deposited publication, beneficiaries must also ensure open access 
– via the repository – to the bibliographic metadata that identify the deposited publication. This 
metadata must include a persistent identifier (such as the Digital Object Identifier, DOI) in order 
to allow easy and persistent referencing.”
European Research Council (ERC) Guidelines 
on Implementation of Open Access to Scientific 




G.8. Reporting Guidelines: “Agreed standards for reporting the outcomes of research in specific 
areas have been developed and should be observed. Standards endorsed and supported by the 
MRC include the CONSORT Statement (CONsolidated Standards of Reporting Trials)40 and the 
ARRIVE guidelines (Animal Research: Reporting in-vivo experiments)41.”
MRC ethics series. Good research practice: Principles 
and guidelines
NIH 5.a. Access & Discoverability: Meta Data. “Ensure full public access to publications’ metadata 
without charge upon first publication in a data format that ensures interoperability with current 
and future search technology. Where possible, the metadata should provide a link to the 
location where the full text and associated supplemental materials will be made available after 
the embargo period; Ensure that attribution to authors, journals, and original publishers is 
maintained (OSTP memo, elements 3c, 3e)”
Plan for Increasing Access to Scientific Publications 




“Metadata [from a research dataset or publication] should be made accessible as soon as 
possible after final acceptance of a paper and appropriate review, even if the full text is subject 
to an embargo period.”
Public Access Plan
World Bank “Requires electronic copies of complete, final manuscripts, as defined above, as well as the 
associated metadata, to be deposited in the Open Knowledge Repository”
World Bank Open Access Policy for Formal 
Publications
World Health Organization Summary of the open-access policy options and requirements: “Publisher deposits XML version 
of the article and metadata in PubMed Central, which automatically appear in Europe PubMed 
Central”
WHO open-access policy: Frequently asked 
questions for recipients of WHO funding
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(From OA policy) “In situations where the AHA or members of the 
research community feel that AHA-funded researchers are not 
sharing data in a manner consistent with our policy, you may be 
asked by the AHA to demonstrate your compliance.”




(From FAQ about OA Policy) 
“The foundation checks and tracks compliancy through Chronos, 
a new service to help you manage the process of publishing 





Nothing stated/identified not specific to journal publication - but have consequences for breaches in policy, 





Supervisors of publishing authors are responsible for ensuring 
compliance with the CDC Public Access Policy.”
None stated/identified
Institut Pasteur (From OA intentions) “The deposit is checked by the CeRIS 
library’s Hal team, in particular when it comes 
to the rights of authors on their files and their affiliations to a lab 
and and institution.”
None stated/identified
JRDF Nothing stated/identified (From Award Terms and Conditions) not specific to publication “JDRF may place the 
PI and/or his/her Grantee Institution on administrative probation if …the Grantee 
Institution is non-compliant as outlined in this document. JDRF administrative 
probation may include, but is not limited to, the following actions: 1. Withholding 
of all payments for the grant/project in question 2. Changing to a payment 
reimbursement schedule 3. Withholding of all JDRF payments for the PI, for any 
JDRF grant 4. Withholding of all JDRF payments for the Grantee Institution, for any 
JDRF grant 5. Any combination of the above”
National Institutes 
of Health
(NIH Public Access Policy) “Compliance with this Policy remains 
a statutory requirement and a term and condition of the grant 
award and cooperative agreement, in accordance with the NIH 
Grants Policy Statement.”
(NIH Public Access Policy - FAQ) “A grantee’s failure to comply with the terms and 
conditions of award may cause NIH to take one or more enforcement actions, 
depending on the severity and duration of the non-compliance. NIH will undertake 
any such action in accordance with applicable statutes, regulations, and policies. 
NIH generally will afford the grantee an opportunity to correct the deficiencies 
before taking enforcement action unless public health or welfare concerns require 
immediate action. However, even if a grantee is taking corrective action, NIH may 
take proactive action to protect the Federal government’s interests, including 
placing special conditions on awards or precluding the grantee from obtaining 
future awards for a specified period, or may take action designed to prevent future 
non-compliance, such as closer monitoring. See Enforcement Actions in the NIH 




“Research commitments shall be reflected in institutional 
policies and program budgeting and planning, implementation, 
monitoring, and evaluation; human resource management; and 
knowledge management.”
None stated/identifiedPage 14 of 31






(From DFID Research Open and Enhanced Access Policy) “As 
part of its monitoring and evaluation framework, DFID Research 
and Evidence Division (RED) collects data on the extent to which 
researchers fulfil the requirements and recommendations of 
this policy. RED researchers are required to report open access 





(From Public Access Plan) “Potential future monitoring plans 
are suggested: “Further criteria/metrics for compliance and 
evaluation will be developed through consultations with 
M/OAA/P, GC, and other USAID Operating Units. This may 
include: A) requesting offerors to submit within their proposals 
a list of USAID-funded peer-reviewed publications (and the 
corresponding DEC-issued unique identifier number for 
publication) that resulted from their prior USAID awards when 
deemed appropriate by the CO; B) importing the metadata and 
links to the authors’ manuscript or the publically available version 
of record of publications that resulted from USAID support, but 
were published after completion of the award in partnership with 
third-party reference services such as CHORUS and FundRef; 
and C) including compliance with open data and public access 
requirements of awards as a measure of past performance.”
None stated/identified
Wellcome Trust (From Complying with our OA policy) “We actively monitor 
research papers authored by our funded researchers to 
ensure they comply with our policy. This includes the review 
of publications listed in ongoing grant reporting and in end of 
grant reports. In addition, Wellcome-funded research papers 
detailed in applications submitted to us are reviewed to ensure 
compliance.”
(From Complying with our OA policy) “When Wellcome-funded researchers do not 
comply with our open access policy, we will apply these sanctions: Applicants will be 
required to ensure that all their Wellcome-funded original research papers resulting 
from current or previous grants are compliant before we issue formal notification of 
any funding renewals or new grants. Where non-compliant research papers, book 
chapters and scholarly monographs are identified in an end of grant report, we will 
withhold the final 10 per cent of the total grant budget until all outputs comply. See 
our 10 per cent retention policy.”
Page 15 of 31
F1000Research 2021, 10:100 Last updated: 30 JU
L 2021
information may be located outside of the main policy web-
pages or documents. If funders wish to provide guidance about 
journal credibility and predatory publishing, they may reach 
more researchers (and increase the likelihood of them reading 
it) by including such information within their main policies.
Comparison to other research
At least four previous studies examining health research 
funder policies on clinical trial transparency have collected 
information on funder’s recommendations for disseminating 
research. 
Two studies using similar methods evaluated trial transparency 
policies (i.e., those related to trial registration, access to sum-
mary results, individual data availability) for non-commercial 
health research funders globally (n=18)34 and in the USA (n=9)36. 
After accounting for three common funders across studies, 
21 of 24 (87.5%) funders (16 of which are represented in our 
study) either required or supported publication or registration of 
trial results (neither study or their available data distinguished 
between publication or registration). This is in line with our 
findings in which 86% (38 of 44) funders had such policies/ 
recommendations.
A third study, published in 2017 which examined research 
waste-reducing policies of 11 non-commercial funders (six of 
which are represented in our study) reported six to be explicit 
in requiring publication of full reports of funded research33. 
In comparison, 36 of 38 policies/recommendations (95%) in our 
study referred to journal publication as one form of dissemination 
for completed research but did not indicate that it was manda-
tory. There may be differences in how authors of that study and 
interpreted language in documents or policies. The names of the 
six funders ‘requiring’ publication in that study were not obvi-
ous in either the publication or available data, so we are unable 
to investigate this further.
A study published in 2008 examined 73 UK and international 
non-commercial health research funders’ guidance for reporting 
funded clinical trials42. 49 funders (67%) explicitly stated 
that trials could or should be published. Of the three funders 
appearing in the 2008 sample and ours, all have maintained 
recommending (but not requiring) the publication of trial results. 
Whether funders provided any guidance on selecting a journal to 
publish in was not collected in the study.
No previous studies appear to have investigated whether 
health research funders’ provide guidance to help funded 
researchers select a journal for publication. Our study appears 
to be the most comprehensive investigation on this matter. 
This is surprising since our findings suggest that funders 
in our sample regard publication as the primary means of 
disseminating funded research. Further, studies show that 
researchers view journal publication as the primary way of 
disseminating research43,44.
Strengths and limitations
This study is the first to examine the information funders 
provide researchers about selecting a journal in which to publish 
funded research. All funders in our sample that mention jour-
nal publication or provide guidance on selecting journals, do so 
within their open access policies. In a time where the scholarly 
publishing landscape has been infiltrated and confused by preda-
tory journals, inadvertently resulting in some researchers try-
ing to achieve open access to publish in predatory journals45, 
funders can play a critical role in steering researchers in the right 
direction. Funders can be specific and explicit with regards to 
which journal features researchers should look for in order to 
select one that meets their open access requirements.
This study provides a benchmark by which to monitor how 
major health research funders are performing pre and post Plan S 
implementation (January 2021). Data collection occurred 
in August & September 2017, prior to the September 2018 
announcement of Plan S. So far, 24 funders have committed to 
implementing Plan S, five of which were considered in this 
research (European Commission, Gates Foundation, MRC/UK 
Research and Innovation, Wellcome Trust, and the World 
Health Organization). Two of these, the Wellcome Trust and 
Gates Foundation, provided guidance (in the form of tools) to 
facilitate selecting a journal in line with their open access poli-
cies at the time of sampling. At least one funder (Wellcome 
Trust) has made changes to their open access policies in 
anticipation of Plan S46.
Our study relied on publicly available information about 
funder expectations of funded research and was abstracted 
by a single person with verification by a second (i.e., not two 
independent people). Six funders in our sample did not pro-
vide any relevant public information. We did not seek verifi-
cation on policies from funders. Data were collected at a time 
when publishing activities, particularly open access, was rap-
idly changing, in part in response to funded research being 
published in predatory journals45,47. We are aware that the NIH 
issued a notice on their Public Access Policy in November 
2017 (outside of our sampling and data collection period) 
with recommendations to publish funded research in journals 
with ‘credible practices’48. Engaging funders in our study may 
have had the added benefit of increasing uptake of our findings/ 
recommendations into practice.
The focus of this research is limited to health research funders. 
We have not accounted for or evaluated other potential sci-
entific publishing gatekeepers such as academic institutions, 
governments, or companies carrying out scholarly research, 
despite the important role they can play49.  
Implications and recommendations for funders
Explicit funder policies on publication expectations. Selecting 
a journal in which to publish research is not a straightforward 
undertaking40, particularly since the emergence of predatory 
journals. For funders looking to make their expectations around 
publishing funded research more explicit and more transpar-
ent, we propose several recommendations on how this might be 
achieved in Box 1, based on findings of this research and on 
the expertise of authors. Providing specific information about 
journal considerations in funders’ policies to funded research-
ers may facilitate more thoughtful and responsible selection 
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of journals. Several recommendations in Box 1 pertain to the 
explicitness of article/journal considerations mentioned in 
Plan S (e.g., persistent identifiers for publications; long-term 
preservation/archiving; article-level metadata). All health 
research funders may wish to consider making aspects of their 
policies that pertain to publishing more explicit, whether or not 
they intend to implement Plan S.
Box 1. Recommendations for providing explicit/
transparent guidance on journal selection in health 
research funders’ open access policies
1.      Use precise wording to describe your agency’s 
expectations that funded research be published
-      Indicate whether researchers are expected to publish 
their research (e.g. use of “must” vs “should”)
-      indicate whether open access publication is one of 
several options for meeting the agency’s open access 
requirements.
2.      Provide a definition of a journal that is suitable to your 
agency
◦      Decide what essential features a publishing entity 
should and should not have in order to be considered a 
suitable place for publication.
◦      Consider referring to/including the Committee 
on Publication Ethics (COPE) list of Core Practices 
all journals and publishers should follow: https://
publicationethics.org/core-practices
◦      The NIH definition of a journal is41:
•   Publication meets the requirements for ISSN 
(International Standard Serial Number) assignment;
•   Publication content is issued over time under a 
common title;
•   Publication is a collection of articles by different 
authors;
•   Publication is intended to be published indefinitely.
3.      Indicate your agency’s requirements for access and 
discoverability of published articles
◦      Distinguish between free vs open access:
•      Published articles are free to access; AND 
additionally, for open access,
•      Licensing for published articles permit reuse 
and building on (typically through a Creative 
Commons Attribution License, CC BY).
◦      Ensure that published research can be accessed in 
perpetuity
○    Researchers can determine whether the 
publishing journal has a permanent archival 
arrangement in place either through automatic 
deposition to PMC (https://www.ncbi.nlm.nih.
gov/pmc/journals/), or to another archive (via 
the Keepers Registry: https://keepers.issn.org/
keepers-registry)xxv 
xxvprovides global monitoring of archiving arrangements for electronic 
journals.
○    PMC-partnered funders can require that 
researchers upload published research directly to 
PMC
°      Journal provides unique permanent identifiers (e.g. 
digital object identifier [DOI]) (can check if journal/
publisher is registered with CrossRef: https://www.
crossref.org/06members/51depositor.html)
4.      Be clear about your agency’s support for article processing 
charges arising from publication of funded research
°      Indicate how much money is available each open access 
publication (e.g. maximum APC amount)
°      Indicate who will receive APC payment from the funder 
– the author (institution) or the journal
°      Indicate when funding will be distributed to support article 
processing charges
°      Indicate whether there are any conditions on distribution 
of APC funds
  5.    Indicate whether your agency requires archiving in a 
repository alongside publication
°      Indicate whether the publication, data, or both, are 
expected to be deposited in a repository
°      Indicate when deposition is expected to occur (i.e., 
immediately or within a specified time frame)
°      Indicate whether you have a dedicated repository for 
research publications (e.g., PMC for NIH-funded research), 
and if not, suggest one or more repositories that are 
considered acceptable by your agency
°      Be clear that it is the authors’ responsibility to ensure 
publications are deposited in a repository
°      Provide instructions/link to resources on how to deposit 
research in the suggested repository.
  6.    Indicate how your agency will monitor that funded research 
is published in appropriate journals, in line with agency 
recommendations/mandates
°      For ease of monitoring, Provide instructions for 
researchers about where and how to include 
the funding agency name and grant number in 
published articles (guidance here: https://www.
ukri.org/wp-content/uploads/2020/10/RIN-251020-
FundersAcknowledgementInScholarlyjournalArticles.pdf)
°      Provide instructions on if, how, and when to submit 
publications of funded research to the funding agency, or 
state how publications will be monitored otherwise
°      Provide specific actions/consequences that the agency will 
carry out when funded research is published in a journal 
that does not meet agency requirements
The NIH is the only funder in our sample to clearly describe 
what it considers a journal – either those listed in the journal 
section of the National Library of Medicine (NLM) (https://www.
ncbi.nlm.nih.gov/nlmcatalog/journals) or those meeting a com-
prehensive set of criteria41: (1) meets the requirements for ISSN 
(International Standard Serial Number) assignment; (2) content 
is issued over time under a common title; (3) is a collection of 
articles by different authors; and (4) is intended to be published 
indefinitely. All but the final criterion are straightforward to judge; 
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presumably it is meant to distinguish a journal from a book or 
a monograph however NIH or NLM do not provide guidance 
on how to judge this criterion. Whether and how we can pre-
dict journals’ intentions to publish indefinitely has not been 
described. A more meaningful criterion for distinguishing jour-
nals from non-journals may be whether the publishing entity 
has archival arrangements in place (e.g., with LOCKSS, Portico, 
PubMed Central) to ensure perpetual access to content in the 
event a journal ceases to operate. Since preserving publisher 
content may have associated costs50, predatory or non-credible 
journals (which some describe as “primarily fee-collecting 
operations”51) may be unlikely to seek this service.
We surprised that the three funders from India in our sample 
(Indian Council for Medical Research, DBT, and DST) did not 
mention journal credibility or predatory journals, and further, 
that a common policy for two Indian funders (DST and DBT), 
dated December 2014, recognizes “the right of researchers to 
publish their work in journals of their choice, because 
researchers are the best judges of where to publish their work”. 
Since at least 2016, there has been an ongoing national initia-
tive combat predatory journals and to support researchers in their 
choice of journals across higher education institutes in India. 
The main product of this work has been a list of approved jour-
nals in which academic researchers are permitted to publish in as 
well as standard templates for researchers when communicating 
with journals52. The University Grants Commission (UGC), the 
regulator and funder of high education, has been leading the 
initiative. It is uncertain whether the country’s largest health 
research funders are on board due to their lack of guidance in this 
space. A coordinated approach by a range of stakeholder groups49, 
which includes funders (who have innate authority to imple-
ment mandates about publishing), may facilitate improved 
publication decisions by researchers. Importantly, how-
ever, UGC’s list of approved journals has been plagued with 
numerous credibility concerns in its short existence53,54. Explicit 
recommendations from India’s funders regarding credible and 
non-credible features of journals in which to publish may be 
warranted in the absence of a trusted and comprehensive 
list.
Facilitating and monitoring adherence to funder policies. 
Funders are well-positioned to provide researchers with resources 
and tools to help ensure that results from funded research are 
published in credible and discoverable journals, in line with their 
policies. Several organizations in our sample consistently offer 
more information about potential publishing routes and tools 
to facilitate adherence to their policies. We provide a list of 
tools to facilitate the development of funder policies on 
research outputs, adherence to such policies, and monitoring of 
policy adherence (Table 8).
Monitoring researchers’ adherence to their policies may help 
funders understand the extent to which researcher’s publishing 
practices are guided by their policies55. Informing researchers 
that their adherence to open access policies is being monitored 
may facilitate better awareness of such policies and potentially 
increase adherence to them56. A 2018 study examining the 
accessibility of research supported by 12 research funding 
agencies across North America and Europe with open access 
policies, found that 62% of almost 1.3 million articles over nine 
years were freely available9. In 2016, 90% of published research 
supported by the NIH and Wellcome Trust was free to access (via 
journal, repository, or both)9. Both agencies mandate the deposit of 
published research by publishing journals or funded authors 
into dedicated repositories (PMC for NIH; PMC Europe for 
Wellcome Trust). The remaining 10 funders in the sample did 
not mandate depositing in a repository alongside publication and 
had lower rates of freely accessible articles. For example, for 
the Canadian Institutes of Health Research (CIHR) only 55% of 
published research was freely accessible in 2016, even though 
the funder had a dedicated repository (PMC Canada) until 
2018 (it closed due to low usage and high upkeep costs)57. 
The study’s authors conclude that funders with low compliance 
rates used less enforcement and had less infrastructure to support 
compliance with their open access mandates9.
Areas of future research
An important area of future study is whether researchers are 
being funded on the basis of grant applications that include research 
published in predatory journals – or in journals that may not be 
indexed in trusted databases. Predatory journals have made their 
way into consideration (via CVs submitted by researchers or 
through institution-initiated database searches) into applications 
for academic career advancement58–60. Some have called for such 
publications to either be discounted from consideration or for 
researchers who submit them for consideration to be prevented 
from career advancement overall61,62. It is unknown whether 
researchers are including publications in predatory journals 
as part of their funding applications. This should be evaluated. 
If they are, funders may wish to consider whether this is an 
important consideration for awarding funding.
Conclusion
Most large health research funders mandate open access to 
funded research outputs, typically by way of open access journal 
publication and by deposition of published research in digital 
repositories. Few funders provide guidance on what constitutes 
a journal (or an open access journal) or are checking to ensure 
that published research that they have funded is indeed meeting 
specified requirements about how research should be shared. 
Health research funding organizations have an obligation 
to support researchers in meeting their mandates so that research 
can, as intended, contribute to the broader evidence base. 
The publishing community needs to provide guidance to funders 
and researchers on universally acceptable and transparent stand-
ards for journal operations. Many solutions to improve policies, 
facilitate adherence, monitor compliance and work with other 
funders on large-scale improvements exist and should be 
implemented.
Journals that fail to make research discoverable breach the 
basic trust that researchers and their funders have in the current 
publishing system. Most funded researchers publish their 
work under the basic assumption that their journal or publisher 
is following best practices to ensure future use7. Bodies funding 
health research have a responsibility to protect their investments 
and even more importantly, to ensure that funded research is not 
wasted by being published in non-credible and non-discoverable 
sources.
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Table 8. Resources and tools that funders can use to support development of, adherence to, and monitoring of open access publishing policies.
Resource/Tool URL Origin Description Relevance & Implementation Limitations
CHORUS https://www.chorusaccess.org/ Association of American 
Publishers
A service that utilizes metadata from CrossRef 
Funder Registry and partner publishers to monitor 
the # of published articles and % that are freely 
accessible; prompts free article access if required 
by funder policies; ensures digital preservation.
FACILITATING ADHERENCE & 
MONITORING: Encourage researchers to 
include funder name and grant number 
in published articles. Ensure funder 
information is registered and correct in 
CrossRef Funding Registry.
Fee-based 
Only able to facilitate 
open access & 
preservation for 
publisher partners (paid 
service).
Chronos https://chronos-oa.com/ The Bill & Melinda Gates 
Foundation
A service facilitating funders’ management and 
tracking of the publication process for funded 
research outputs, through which pay APCs, and by 
which to manage subsequent archiving. 
Automatically collects information on where 
research was published, whether, when, and in 
which repositories published research and data 
were deposited, and the type of license research 
was published under.
FACILITATE ADHERNCE: Require that 
researchers use Chronos to submit 
any funder-supported research for 
publication; pay APCs directly to 
publishers instead of distributing as 
grant funding. 
MONITOR ADHERENCE: 
Use to monitor # of open access 
publications. Use as grant reporting tool 
to alleviate researchers of administrative 
responsibility.
Fee-based 





https://search.crossref.org/funding CrossRef Tracks any published articles with a digital object 
identifier (DOI) issued by Crossref (main DOI 
registration organization) and for which funder 
metadata is available
MONITOR ADHERENCE: Ensure funder 
information is registered and correct 
in the Registry; use to search for 
publications and other research outputs 
with DOIs funded by a specific grant or 
by a funder overall. 
No distinction between 
freely available vs. 
subscription content. 
Only able to track articles 
for which publishers 
have registered DOIs 
and funding metadata 
with Crossref (paid 
service). 
Dependent on authors 
reporting funding 
information during the 
submission process or 








Open Research Funders 
Group; SPARC 
Freely available framework for designing funders’ 
open access policies. Provides policy examples 
along a spectrum of openness for five aspects of 
research outputs: article access, data and code 
access, reuse, costs, and compliance.
POLICY DEVELOPMENT: Use to 
facilitate design of a policy that includes 
recommendations on one or more 
aspects of openness of research outputs, 
that are feasible/desired.
None
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Resource/Tool URL Origin Description Relevance & Implementation Limitations
OpenAire https://monitor.openaire.eu/ European Commission/
Horizon 2020
Uses metadata provided by a funder (i.e., grant 
number) to search for funded research outputs 
deposited in digital archives/repositories.
MONITOR ADHERENCE: 
Use to collect data on research outputs 
(including publications) that are available 
in repositories.




grant numbers within 
research outputs 
deposited in repositories. 






https://www.ncbi.nlm.nih.gov/pmc NIH The US National Library of Medicine’s (NLM) 
repository of freely available, full-text, published 
biomedical and life sciences articles; Dedicated 
repository for published NIH-funded research 
and for select other US and international funders. 
Publications can be deposited by journals with 
agreements with PMC or by researchers reporting 
NIH (or other agreed funder-) supported research.
FACILITATE ADHERNCE: Take appropriate 
steps to partner with PMC, Europe PMC, 
or the Health Research Alliance (NLM 
partner): https://www.ncbi.nlm.nih.gov/
pmc/about/public-access/. 
Require that all publications from funded 
research are deposited in PMC via a 
publishing journal or by authors. 
Relies on journals 
agreeing to deposit 
to PMC or on authors 
to deposit published 







http://sherpa.ac.uk/fact/ Jisc; Wellcome Trust; 
Research Councils UK
Free online tool for researchers funded by the 
Wellcome Trust and members of Research 
Councils UK to check whether their intended 
journal meets funder open access requirements. 
FACILITATE ADHERNCE: Request inclusion 
to be listed in FACT from Jisc. Direct 
funded researchers to use FACT to select 
a journal in which to publish in.
Relies on authors to use. 
Restricted to searching 
journals for which open 




https://thinkchecksubmit.org Publishing community 
led (collaboration 
among many publishing 
professionals/
organizations)
Freely available checklist to facilitate researchers 
in selecting a relevant and trustworthy journal 
in which to submit their research for publication 
consideration
FACILITATE ADHERNCE: Encourage 
authors to use checklist to facilitate 
selection of credible journal.
Relies on authors to 
read/understand/use 
Uncertain development 
process and validity of 
checklist items. 
xxviPreviously known as FundRef (until Nov 2015).
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Open Science Framework: Audit of health research funder poli-
cies and recommendations on journal publication of research: 
Extracted Data, https://doi.org/10.17605/OSF.IO/YUDP463.
This project contains the following underlying data:
     -     Funders Data analysis data - clean 2020Apr21.dta
Extended data
Open Science Framework: Audit of health research funder 
policies and recommendations on journal publication of research: 
Study Forms, https://doi.org/10.17605/OSF.IO/FSUQ264
This project contains the following extended data:
     -     Level 1 - Searching funder websites form 2017Nov23.pdf
     -     Level 2 - Data extraction form 2017Nov23.pdf
Open Science Framework: Audit of health research funder 
policies and recommendations on journal publication of research: 
Protocol, https://doi.org/10.17605/OSF.IO/J6CSK65
Registration of overarching OSF project: https://doi.org/ 
10.17605/OSF.IO/Z59U666.
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0). 
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Nicholas Devito   
The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, 
UK 
Many thanks to the authors for their consideration of my review and their revisions. While many of 
my comments were addressed, I do have some additional feedback based on the responses from 
the authors that I believe should be further considered. That said, these are all relatively minor 
enough that I recommend the manuscript move forward for indexing as the analysis and related 
discussion is overall fundamentally sound. 
 
-As indicated, Dr. Holmes is the CEO of a health research funding organization (not included 
in our sample). Her expertise of the funding landscape and whether a listing of health 
research funders existed or whether the chosen list was the best source of this information, 
was an invaluable methodological contribution to our research. We prefer not to remove 
this acknowledgment. 
 
I still believe this reads awkwardly in the text and is not how personal communication citations are 
typically used. If it is just an acknowledgement it is ultimately redundant to your thanks of Dr. 
Holmes in the “Acknowledgements” section at the end of the piece. However this is a minor point. 
 
-Extraction criteria were devised de novo based on expertise within the author team. There 
is no reference standard for funder policies about publishing and as such we did not use any 
framework for extraction. We have added a clarification of this point in the methods section 
rather than in the discussion section. 
 
The addition to the methods is appropriate although I do believe there is an argument to be made 
that using criteria developed in-house based on expertise, while an acceptable method, could be 
seen as a limitation as it is lacking further validation and consideration beyond the study team. 
 
-We did not apply an analytical framework to the extracted text and doing so would be a 
post-hoc analysis. The table/text is provided for reference/transparency of extracted data 
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summarized in Tables 2-4. We do not feel that a summary is necessary. 
 
I do not agree that a full analytic framework is required to condense multiple tables of raw 
verbatim text within the body of a manuscript into something more easily digestible to readers. I 
still strongly recommend that the authors reconsider the utility that 7 pages of Tables in the 
middle of the manuscript (including 4 pages just for Table 5) has for readers when Tables 2-4 
summarize the extractions from this raw data as necessary for the endpoints considered and 
interested parties could examine the very well-curated, transparent, and clearly sign-posted raw 
data for themselves as necessary. 
 
-To be clear, we did not make a post-hoc justification regarding the lack of outreach to 
funders. We specifically did not have the a priori intent of verifying our data with funders. 
We anticipated that the results of our previous work, https://www.nature.com/news/stop-
this-waste-of-people-animals-and-money-1.22554, which identified a large number of 
funders supporting research in predatory journals, may impact/prompt changes in funder 
policies once published (Sept 2017). Due to the timing of the current study, (Aug – Sept 2017), 
we decided not to engage funders since we did not want to influence any potential changes 
to their policies as a result of the study process. We did not find this to be a limitation. As 
expected, and as noted in our discussion, we are aware of at least one funder (NIH) who, in 
Nov 2017, clarified their policies about publication as a result of the previous study. The 
specific impacts (i.e., number and type of clarifications) of engaging funders to clarify 
extracted data in Goldacre et al’s previous work are unclear, however, we have added text 
to the limitations section outlining the additional potential benefit of engaging funders in 
the study process. 
 
While it is true that outreach to sponsors was not specified in the protocol, it is also true that the 
justification for not doing so was also not provided in the protocol despite the fact that it was used 
in the study cited as informing your data collection/extraction methods. Therefore, while the 
decision not to conduct outreach was not post hoc there is no way to know if the provided 
justification was or not. In my original reading the provided information was not well-supported 
by even your own findings. Expanding on the context provided above in your revision is helpful 
however there is another aspect at play here. You relied on a single author for searches and only 
involved a second party for extractions. There is no acknowledgement of the potential that 
documents could have been missed by a single searcher. Outreach to the parties under 
investigation would allow them to confirm whether or not you have missed potentially relevant 
documentation on the topics of interest. It is a validation step for your methods rather than simply 
a way to potentially increase “uptake of our findings/ recommendations into practice.”
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Nicholas Devito   
The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, 
UK 
Many thanks for the opportunity to review this piece on health research funders’ policies on 
journal selection for research outputs. 
 
Overall, this piece investigates an interesting topic, has appropriate methods, appears well-
executed, and follows open science best principles of pre-registration and open sharing of data for 
which it should be commended. I ultimately believe it should be recommended for indexing but a 
minor revision is in order. Specific points are provided below. 
 
Can the authors please revisit the piece for a bit of editing? The informational content all appears 
very relevant and well-researched but the prose can carry on at times and structurally it jumps 
back and forth between topics and it is difficult to connect the threads. This is most applicable to 
the introduction (and perhaps the Discussion as well) but I think taking a critical eye towards 
developing a more direct, succinct, and straight-forward writing style throughout would enhance 
readability. A sharper consolidation and organisation of your ideas and arguments, while trying to 
be more concise overall, will aid readers considerably. A brief example: “Funders ought to be 
concerned that funded research may be published in journals that do not ensure discoverability of 
content ensuring it is available to contribute to future science” could surely be consolidated to 
something like “Funders should ensure published research is discoverable to the scientific 
community.”  
 
One area that doesn’t really come through clearly in the Intro is what funders get out of 
publication of their funded work and how this influences this dynamic. Why are they moving 
towards Open Access? What about other dissemination routes? 
 
The personal communication citation of Dr. Beverly Holmes feels a bit out of place. Is she merely 
stating an opinion? If so, why can the authors not just state this opinion directly themselves since I 
assume they share it? I’m sure Dr. Holmes is perfectly knowledgeable and her opinion is valuable, 
but is citing her necessary here? I’m most familiar with citations of personal communication to 
convey official information not published elsewhere, from a direct source, rather than simply used 
to state an opinion the authors agree with. The average reader won’t have any insight as to why 
they should trust the word of Dr. Holmes on this issue. 
 
The link to the protocol is upfront and clear and points readers to exactly where they can easily 
access more detailed information about the search/data extraction methods. Very well done by 
the authors. 
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How were the extraction criteria derived? Did the authors base them on anything or did they come 
up with them de novo? This should be stated and potentially explored in the Discussion. 
 
One major area I was surprised that the authors did not include in their assessments is whether 
the funder offers to pay the open access/APCs of work they fund. This would be an important part 
of the dynamic of how, where, and why certain journals may be chosen and why funders should 
care even more about where the research they fund ends up. 
 
In Figure 1, it is unclear when INSERM is mentioned as to whether that is the funder being 
removed or the reason another funder is being removed (later context shows it’s the latter, but 
this is unclear). Also there is a type (“allocated”) in the “Excluded Funders n=6” box. I think ideally 
you would list which exact funders are entering or exiting the sample in this figure for clarity as 
you don’t get a good sense of what funders are actually being assessed until the results. It’s also 
not necessary to restate in prose everything Figure 1 already conveys (something to be cognisant 
of throughout). 
 
Table 5 is a bit overwhelming. Perhaps consider summarising each policy in Table 5 and make the 
full text extractions available as an appendix for interested readers. 
 
I don’t find the reason given for a lack of outreach to sponsors particularly compelling. The 
author’s state they did not verify with sponsors (despite this being a feature of the work from 
Goldacre et al. they cite as a template for this research) because “data collection took place at a 
time when the publishing activities...was rapidly changing.” That seems like a post hoc justification 
rather than an actual reason why it didn’t actually occur. It also isn’t supported by their own data 
as the median date of effect of policies reported was September 2014, 3 years prior to data 
collection and the higher IQR range is April 2016, over a year before the searches. Similarly, this 
article is cross-sectional, so I don’t see that reason as relevant anyway. You could simply have 
discarded policies from before a cutoff date, etc. Can the authors please revisit their discussion of 
this limitation? 
 
Table 8 may fit better in an appendix.
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Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Metascience, health policy, publication ethics.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
Author Response 01 Apr 2021
Larissa Shamseer, University of Ottawa, Ottawa, Canada 
Thank you for reviewing this work. Please see responses to your comments below.
We have made some changes in the introduction and discussion sections to make the 
wording more concise. 
○
We have clarified that scholarly publishing is intended to facilitate the discoverability 
and uptake of funded research (into practice) and that predatory journals limit this by 
having unreliable discovery and questionable trustworthiness. We did not set out to 
investigate funders’ open access (OA) policies or shifts towards OA since 
discoverability and other journal features compromised by predatory journals can be 
achieved independent of openness. We note that several sources (ROARMAP, SHERPA 
JULIET)  list details of funders' open access policies. This research is instead 
concerned with hallmarks of journal validity which have been (mis)taken as signals of 
research quality.
○
Regarding other dissemination routes, we have clarified that this research focuses on 
journal publications rather than other publications routes (end of introduction 
section).
○
As indicated, Dr. Holmes is the CEO of a health research funding organization (not 
included in our sample). Her expertise of the funding landscape and whether a listing 
of health research funders existed or whether the chosen list was the best source of 
this information, was an invaluable methodological contribution to our research. We 
prefer not to remove this acknowledgment.
○
Extraction criteria were devised de novo based on expertise within the author team. 
There is no reference standard for funder policies about publishing and as such we 
did not use any framework for extraction. We have added a clarification of this point 
in the methods section rather than in the discussion section.
○
We have added text to the introduction (2nd para) outlining the waste of research 
funds & APCs due to predatory journals. While we did not extract specific data on 
funders' APC provisions, where funders provided information about journal APC 
support, this can be found in Table 5.
○
We have updated the suggested information in the flow diagram and left the related 
descriptive text in results for additional reference.
○
We did not apply an analytical framework to the extracted text and doing so would be 
a post-hoc analysis. The table/text is provided for reference/transparency of extracted 
data summarized in Tables 2-4. We do not feel that a summary is necessary.
○
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To be clear, we did not make a post-hoc justification regarding the lack of outreach to 
funders. We specifically did not have the a priori intent of verifying our data with 
funders. We anticipated that the results of our previous work, 
https://www.nature.com/news/stop-this-waste-of-people-animals-and-money-
1.22554, which identified a large number of funders supporting research in predatory 
journals, may impact/prompt changes in funder policies once published (Sept 2017). 
Due to the timing of the current study, (Aug – Sept 2017), we decided not to engage 
funders since we did not want to influence any potential changes to their policies as a 
result of the study process. We did not find this to be a limitation. As expected, and as 
noted in our discussion, we are aware of at least one funder (NIH) who, in Nov 2017, 
clarified their policies about publication as a result of the previous study. The specific 
impacts (i.e., number and type of clarifications) of engaging funders to clarify 
extracted data in Goldacre et al’s previous work are unclear, however, we have added 
text to the limitations section outlining the additional potential benefit of engaging 
funders in the study process.
○
F1000 does not allow appendices and we have opted not to move this table to the 
Open Science Framework repository for this project as supplementary materials. We 
feel that the recommendations in this table are part of our discussion and are likely to 
receive little uptake if readers have to navigate away from the full text.
○
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The purpose of this work is clear and the work is explicitly and precisely presented. Researchers 
would like to describe the policies of major health research funding agencies. The job is sound 
technically. 
 
Authors selected policies from 44 funding agencies and assessed systematically to find 
information and recommendations on the dissemination of research output, recommendations on 
criteria for the selection of journals (quality, impact factor and other metrics). 
 
Methodology for data collection and analysis is discussed very well and the protocol followed is 
described in detail. 
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Statistical data can be interpreted easily. Source data can be reproducible. 
 
The results obtained through this exercise are well discussed and will be of interest to all funding 
agencies, especially those from developing countries. The findings of the study show that there is 
no specific guidance about how to select a journal for publication. The mention and cautionary 
notes on predatory publishers and their open-access nature should be made clear by these 
funding agencies. Authors warned policymakers about this. If the policy of these funding agencies 
advises researchers to current trends in publishing, researchers may not fall into pray with 
predatory publishers. 
 
Overall, this work is recommended for indexing. Similar studies can be considered for the 
assessment of policies of funding agencies other than health research funders.
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Competing Interests: No competing interests were disclosed.
 
Page 30 of 31
F1000Research 2021, 10:100 Last updated: 30 JUL 2021
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias•
You can publish traditional articles, null/negative results, case reports, data notes and more•
The peer review process is transparent and collaborative•
Your article is indexed in PubMed after passing peer review•
Dedicated customer support at every stage•
For pre-submission enquiries, contact research@f1000.com
 
Page 31 of 31
F1000Research 2021, 10:100 Last updated: 30 JUL 2021
